Cogent Biosciences Analyst Ratings
Cogent Biosciences Analyst Ratings
Cogent Biosciences Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Piper Sandler Sticks to Their Buy Rating for Cogent Biosciences (COGT)
Neutral Hold Rating on Cogent Biosciences With a $8 Price Target Amidst Clinical and Market Evaluation
Cogent Biosciences Analyst Ratings
Buy Rating on Cogent Biosciences: Financial Stability and Promising Clinical Trials Fuel Positive Outlook
Analyst Issues Buy Rating on Cogent Biosciences Amid Clinical and Financial Milestones
Analysts Offer Insights on Healthcare Companies: Clover Health Investments (CLOV), Cogent Biosciences (COGT) and Adaptive Biotechnologies (ADPT)
Cogent Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT) and Inozyme Pharma (INZY)
Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Celldex (CLDX) and Laboratory (LH)
Cogent Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Cogent Biosciences (COGT) and Canopy Growth (CGC)
Cogent Biosciences Analyst Ratings
Cogent Downgraded at Baird on Rare Disease Drug Data
Cogent Biosciences Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT) and Moderna (MRNA)
Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)